MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Neoplasms, Glandular and Epithelial

(UMLS:C0027660)

Definition:: Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.
UMLS ID:: C0027660
MeSH ID:: D009375

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.470

Synonym(s)

Neoplasms, Glandular and Epithelial

Associated Drug(s)

	Name	Reference(s)	Data Source
1	1-chloro-2-methylpropene	12748737 21860474	CTD
2	Arsenicals	21447609	CTD
3	Diethylstilbestrol	2040004	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	leukemia	42.9%
2	Neoplasms, Germ Cell and Embryonal	42.9%
3	Germ Cell Cancer	42.9%
4	Neuroectodermal Tumors	40.9%
5	melanoma	37.2%
6	Carcinosarcoma	37.1%
7	Hemangiosarcoma	37.1%
8	lymphangiosarcoma	37.1%
9	Chondrosarcoma	33.3%
10	Craniopharyngioma	33.3%
11	leiomyosarcoma	33.3%
12	liposarcoma	33.3%
13	synovial sarcoma	33.3%
14	Neuroectodermal Tumor, Melanotic	33.3%
15	Angiomyolipoma	33.3%
16	Clear Cell Sarcoma of Soft Tissue	33.3%
17	Alveolar Soft Part Sarcoma	33.3%
18	Neuroendocrine Tumors	33.3%
19	Sarcoma, Myeloid	33.3%
20	Neurilemmoma	33.1%
21	Hutchinson's Melanotic Freckle	33.1%
22	Melanoma, Amelanotic	33.1%
23	Fibrosarcoma	31.5%
24	Osteosarcoma	31.5%
25	Ameloblastoma	31%
26	Angiokeratoma	31%
27	Chordoma	31%
28	Hemangioma	31%
29	hemangiopericytoma	31%
30	Lymphangioma	31%
31	Mesenchymoma	31%
32	Nevus	31%
33	Teratoma	31%
34	Hepatoblastoma	31%
35	Mixed Tumor, Mullerian	31%
36	Germinoma	31%
37	Teratocarcinoma	31%
38	Angiofibroma	31%
39	Sarcoma	31%
40	Carcinoma 256, Walker	30.8%
41	Malignant Fibrous Histiocytoma	30.6%
42	Paraganglioma	29.7%
43	Rhabdomyosarcoma	29.7%
44	Giant Cell Tumor of Bone	29.7%
45	Dermatofibrosarcoma	28.8%
46	Dermatofibrosarcoma Protuberans	28.8%
47	Histiocytic Disorders, Malignant	27.9%
48	Pheochromocytoma	27.9%
49	Alveolar rhabdomyosarcoma	27.9%
50	Leukemia, Plasma Cell	27.5%
51	Meningioma	26.9%
52	Melanoma, Experimental	26.7%
53	Dermoid Cyst	26.4%
54	Phyllodes Tumor	25.4%
55	Dysgerminoma	25.4%
56	Hemangioendothelioma	25.4%
57	Lipoma	25.4%
58	Myoma	25.4%
59	Myxoma	25.4%
60	Neuroma	25.4%
61	Seminoma	25.4%
62	Angiolipoma	25.4%
63	Myelolipoma	25.4%
64	Neoplasms, Bone Tissue	25.4%
65	Neoplasms, Fibrous Tissue	25.4%
66	Smooth Muscle Tumor	25.4%
67	Desmoplastic Small Round Cell Tumor	25.4%
68	Chondroma	25.4%
69	Enchondroma	25.4%
70	Neoplasms, Neuroepithelial	25%
71	Gliomatosis cerebri	25%
72	Composite Lymphoma	24%
73	Leukemia L1210	23.6%
74	Leukemia P388	23.6%
75	Medulloblastoma	23.4%
76	Hamartoma	23.1%
77	Neoplasms, Hormone-Dependent	23.1%
78	Neoplasms, Multiple Primary	23.1%
79	Paraneoplastic Syndromes	23.1%
80	Precancerous Conditions	23.1%
81	Neoplasms, Second Primary	23.1%
82	fibroma	22.7%
83	Fibromatosis	22.7%
84	Osteoblastoma	22.7%
85	Osteoma	22.7%
86	Rhabdomyoma	22.7%
87	Chondromatosis	22.7%
88	Hemangioblastoma	22.7%
89	Lymphoma, Extranodal NK-T-Cell	22.7%
90	Trophoblastic Neoplasms	22.4%
91	Leukemia, Experimental	22.2%
92	Adenoma, Acidophil	22.1%
93	Ganglioneuroma	22.1%
94	Glioma	22.1%
95	Malignant Glioma	22.1%
96	Carcinoid Tumor	22%
97	Sarcoma 180	21.8%
98	Neurofibrosarcoma	21.4%
99	Fibromatosis, Aggressive	21.3%
100	Fibromatosis, Abdominal	21.3%
101	Astrocytoma	20.7%
102	Ependymoma	20.7%
103	oligodendroglioma	20.7%
104	Ganglioglioma	20.7%
105	gliosarcoma	20.7%
106	Anaplastic astrocytoma	20.7%
107	Anaplastic Oligodendroglioma	20.7%
108	Lymphoma	20.7%
109	Malignant Carcinoid Syndrome	20.7%
110	Endometrial Stromal Sarcoma	20.6%
111	Plasmacytoma	20.5%
112	Malignant histiocytosis	20.2%
113	Histiocytic sarcoma	20.2%
114	Glioblastoma	20%
115	Neuroblastoma	20%
116	Glioblastoma Multiforme	20%
117	Lymphangioleiomyomatosis	19.7%
118	Ganglioneuroblastoma	19.7%
119	Sarcoma, Experimental	19.5%
120	Thymoma	19.3%
121	Leukemia, Radiation-Induced	17.9%
122	Leukemia, Myelomonocytic, Chronic	16.7%
123	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	16.7%
124	Carcinoid Heart Disease	16.3%
125	Acoustic Neuroma	15.7%
126	Hydatidiform Mole	15.2%
127	Mastocytoma	15.1%
128	Cyst	15%
129	Hodgkin Disease	15%
130	Lymphoma, Non-Hodgkin	15%
131	Neoplastic Processes	15%
132	Neoplastic Syndromes, Hereditary	15%
133	Pregnancy Complications, Neoplastic	15%
134	Mastocytosis, Systemic	14.9%
135	Leukemia, Myeloid, Chronic-Phase	14.8%
136	Neoplasms, Experimental	14.6%
137	Abdominal Neoplasms	14.3%
138	Erythroplasia	14.3%
139	Follicular cyst	14.3%
140	Head and Neck Neoplasms	14.3%
141	Mucocele	14.3%
142	Pilonidal Cyst	14.3%
143	Soft Tissue Neoplasms	14.3%
144	Thoracic Neoplasms	14.3%
145	Thyroglossal Cyst	14.3%
146	Synovial Cyst	14.3%
147	Aberrant Crypt Foci	14.3%
148	Lymphomatoid Granulomatosis	14.2%
149	Adenofibroma	14%
150	Fibroadenoma	14%
151	Choriocarcinoma	13.9%
152	Retinoblastoma	13.3%
153	Mastocytosis	12.8%
154	Sturge-Weber Syndrome	12.8%
155	Multiple Endocrine Neoplasia	12.8%
156	Gastrointestinal Stromal Tumors	12.6%
157	Hemangioma, Cavernous	12.5%
158	Leukemia, T-Cell	12.4%
159	Leukemia, B-Cell	12.4%
160	neurofibroma	12.3%
161	Lymphoma, Follicular	12.3%
162	T-Cell Lymphoma	12.3%
163	Mantle cell lymphoma	12.3%
164	Paraneoplastic Encephalomyelitis	12.3%
165	Primary amyloidosis	12.1%
166	Mammary Neoplasms, Experimental	12%
167	Nephroblastoma	11.2%
168	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	11%
169	Leukemia, Large Granular Lymphocytic	11%
170	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	11%
171	Lymphoma, T-Cell, Cutaneous	11%
172	Lymphoma, AIDS-Related	11%
173	Enteropathy-Associated T-Cell Lymphoma	11%
174	Primary Effusion Lymphoma	11%
175	Dupuytren Contracture	10.8%
176	Neoplasms, Radiation-Induced	10.8%
177	Urticaria Pigmentosa	10.6%
178	Mesoblastic Nephroma	10.5%
179	Retroperitoneal Neoplasms	10.3%
180	Mycosis Fungoides	10.3%
181	Lymphomatoid Papulosis	10.3%
182	Plasmablastic lymphoma	10.3%
183	Optic Nerve Glioma	10.1%
184	Digestive System Neoplasms	10%
185	Endocrine Gland Neoplasms	10%
186	Eye Neoplasms	10%
187	Nervous System Neoplasms	10%
188	Bone neoplasms	9.5%
189	Leukoplakia	9.5%
190	Lymphocele	9.5%
191	Pancreatic Cyst	9.5%
192	Skin Neoplasms	9.5%
193	Hematologic Neoplasms	9.5%
194	Multiple Endocrine Neoplasia Type 1	9.4%
195	granulosa cell tumor	9.3%
196	Barrett Esophagus	9.3%
197	Breast Cyst	9.3%
198	Actinic keratosis	9.3%
199	Mediastinal Cyst	9.3%
200	Neoplasm Invasiveness	9.3%
201	Neoplasm Metastasis	9.3%
202	Neoplasm Recurrence, Local	9.3%
203	Parovarian Cyst	9.3%
204	Pericardial Cyst	9.3%
205	Splenic Neoplasms	9.3%
206	Thymic Cyst	9.3%
207	Carcinogenesis	9.3%
208	Myxoid cyst	9.3%
209	Metastasis	9.3%
210	Carcinoma, Ehrlich Tumor	9.2%
211	Carcinoma, Lewis Lung	9.2%
212	Leydig Cell Tumor	9%
213	Vipoma	8.8%
214	Waldenstrom Macroglobulinemia	8.6%
215	Multiple Myeloma	8.6%
216	Parathyroid Neoplasms	8.3%
217	Peritoneal Neoplasms	8.3%
218	Thyroid Neoplasm	8.3%
219	Thyroid carcinoma	8.3%
220	Tuberous Sclerosis	8.2%
221	Tracheal Neoplasms	7.6%
222	Leukoplakia, Oral	7.4%
223	Burkitt Lymphoma	7.3%
224	Paraneoplastic Cerebellar Degeneration	7.3%
225	Liver Neoplasms, Experimental	7.3%
226	Mouth Neoplasms	7%
227	Pancreatic Neoplasm	7%
228	Central Nervous System Neoplasms	7%
229	Vascular Neoplasms	7%
230	Thymus Neoplasms	7%
231	Sezary Syndrome	6.9%
232	Genital Neoplasms, Female	6.8%
233	Pancreatic Pseudocyst	6.8%
234	Corpus Luteum Cyst	6.8%
235	Ovarian Cysts	6.8%
236	Lymphatic Metastasis	6.7%
237	Neoplasms, Unknown Primary	6.7%
238	Leukemic Infiltration	6.7%
239	Breast Neoplasms, Male	6.7%
240	Acanthoma	6.7%
241	Neoplasm Micrometastasis	6.7%
242	Triple Negative Breast Neoplasms	6.7%
243	Thyroid Nodule	6.7%
244	Denys-Drash Syndrome	6.3%
245	Esophageal Neoplasms	6.1%
246	Limbic Encephalitis	6.1%
247	Meningeal Neoplasms	5.6%
248	Choledochal Cyst	5.6%
249	Peutz-Jeghers Syndrome	5.4%
250	Lambert-Eaton Myasthenic Syndrome	5.3%
251	Testicular Neoplasms	5.3%
252	Adrenal Gland Neoplasms	5.3%
253	Gastrointestinal Neoplasms	5.3%
254	Genital Neoplasms, Male	5.3%
255	Liver neoplasms	5.3%
256	Uveal Neoplasms	5.3%
257	Urologic Neoplasms	5.2%
258	Sebaceous Gland Neoplasms	5.1%
259	Spinal Neoplasms	5.1%
260	Bone Marrow Neoplasms	5.1%
261	Meningeal Carcinomatosis	5%
262	Polycystic Ovary Syndrome	5%
263	Opsoclonus-Myoclonus Syndrome	4.6%
264	Palatal Neoplasms	4.5%
265	Ear Neoplasms	4.3%
266	Eyelid Neoplasms	4.3%
267	Lung Neoplasms	4.3%
268	Pleural Neoplasms	4.3%
269	Nose Neoplasms	4.3%
270	Cell Transformation, Viral	4.2%
271	Brain Neoplasms	4.2%
272	Salivary Gland Neoplasms	4.2%
273	Spinal Cord Neoplasms	4.2%
274	Tongue Neoplasms	4.2%
275	insulinoma	4.2%
276	Gastrinoma	4.2%
277	Glucagonoma	4.2%
278	Basal Cell Nevus Syndrome	4.1%
279	Uterine Neoplasms	4.1%
280	Vaginal Neoplasms	4.1%
281	Vulvar Neoplasms	4.1%
282	Uterine Cancer	4.1%
283	Fallopian Tube Neoplasms	4.1%
284	Carcinoma, Pancreatic Ductal	4.1%
285	Myelitis, Transverse	4%
286	Adenomatous Polyposis Coli	4%
287	Carcinoma, Lobular	4%
288	Bronchial Neoplasms	3.8%
289	Multiple Pulmonary Nodules	3.8%
290	Pituitary Adenoma	3.7%
291	Pituitary Neoplasms	3.7%
292	Supratentorial Neoplasms	3.7%
293	Endometrial Neoplasms	3.7%
294	Pharyngeal Neoplasms	3.5%
295	Brain Stem Neoplasms	3.5%
296	Central Nervous System Cysts	3.4%
297	ovarian neoplasm	3.4%
298	Bile Duct Neoplasms	3.4%
299	gallbladder neoplasm	3.4%
300	Intestinal Neoplasms	3.4%
301	Penile Neoplasms	3.4%
302	Prostatic Neoplasms	3.4%
303	Stomach Neoplasms	3.4%
304	Choroid Plexus Papilloma	3.3%
305	Hepatocellular Adenoma	3.3%
306	Polycythemia Vera	3.3%
307	Hypopharyngeal Neoplasms	3%
308	Pleural Effusion, Malignant	3%
309	Hypopharyngeal Cancer	3%
310	Xeroderma Pigmentosum	3%
311	Parotid Neoplasms	3%
312	Prostatic Neoplasms, Castration-Resistant	3%
313	Nelson Syndrome	2.9%
314	Laryngeal neoplasm	2.9%
315	Tonsillar Neoplasms	2.8%
316	Cerebellar Neoplasms	2.8%
317	Bladder Neoplasm	2.8%
318	Kidney Neoplasm	2.8%
319	Ureteral Neoplasms	2.8%
320	Urethral Neoplasms	2.8%
321	Prolactinoma	2.8%
322	Growth Hormone-Secreting Pituitary Adenoma	2.8%
323	Zollinger-Ellison syndrome	2.5%
324	Cecal Neoplasms	2.5%
325	Duodenal Neoplasms	2.5%
326	Adrenocortical carcinoma	2.4%
327	Carcinoma, Ovarian Epithelial	2.3%
328	Radicular Cyst	2.3%
329	Appendiceal Neoplasms	2.3%
330	Colonic Neoplasms	2.3%
331	Rectal Neoplasms	2.3%
332	Nasopharyngeal Neoplasms	2.1%
333	Colorectal Neoplasms	2.1%
334	Renal Cell Carcinoma	2.1%
335	Papillary Renal Cell Carcinoma	2.1%
336	Carcinoma, Endometrioid	2%
337	Anus Neoplasms	1.9%
338	Sigmoid Neoplasms	1.9%
339	Paranasal Sinus Neoplasms	1.9%
340	Maxillary Sinus Neoplasms	1.7%
341	Nasopharyngeal carcinoma	1.7%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234